Efficacy and Safety of Interferon-Alpha 2b for Patients with Hepatic Epithelioid Hemangioendothelioma: Outcomes of a Case-Series Analysis

References

• Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50(5):970–981. doi:10.1002/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z7093931
   PubMed Web of Science ®Google Scholar
• Sardaro A, Bardoscia L, Petruzzelli MF, Portaluri M. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev. 2014;8:259.25992243
   PubMedGoogle Scholar
• Lai Q, Feys E, Karam V, et al. Hepatic epithelioid hemangioendothelioma and adult liver transplantation: proposal for a prognostic score based on the analysis of the ELTR-ELITA registry. Transplantation. 2017;101(3):555–564. doi:10.1097/TP.000000000000160328212256
   PubMed Web of Science ®Google Scholar
• Rodriguez JA, Becker NS, O’Mahony CA, Goss JA, Aloia TA. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg. 2008;12(1):110–116. doi:10.1007/s11605-007-0247-317710508
   PubMed Web of Science ®Google Scholar
• Nudo CG, Yoshida EM, Bain VG, et al. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can J Gastroenterol. 2008;22(10):821–824. doi:10.1155/2008/41848518925305
   PubMed Web of Science ®Google Scholar
• Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol. 2008;15(2):415–423. doi:10.1245/s10434-007-9658-317987343
   PubMed Web of Science ®Google Scholar
• Lerut JP, Orlando G, Adam R, et al. The place of liver transplantation in the treatment of hepatic epithelioid hemangioendothelioma: report of the European liver transplant registry. Ann Surg. 2007;246(6):949–957. doi:10.1097/SLA.0b013e31815c2a7018043096
   PubMed Web of Science ®Google Scholar
• Mascarenhas RCV, Sanghvi AN, Friedlander L, Geyer SJ, Beasley HS, Van Thiel DH. Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology. 2004;67(5–6):471–475. doi:10.1159/00008293215714004
   PubMed Web of Science ®Google Scholar
• Galvao FHF, Bakonyi-Neto A, Machado MAC, et al. Interferon alpha-2B and liver resection to treat multifocal hepatic epithelioid hemangioendothelioma: a relevant approach to avoid liver transplantation. Transplant Proc. 2005;37(10):4354–4358. doi:10.1016/j.transproceed.2005.11.02216387119
   PubMed Web of Science ®Google Scholar
• Idilman R, Dokmeci A, Beyler AR, et al. Successful medical treatment of an epithelioid hemangioendothelioma of liver. Oncology. 1997;54(2):171–175. doi:10.1159/0002276839075791
   PubMed Web of Science ®Google Scholar
• St Peter SD, Moss AA, Huettl EA, Leslie KO, Mulligan DC. Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma. Clin Transplant. 2003;17(6):549–553. doi:10.1046/j.1399-0012.2003.00055.x14756273
   PubMed Web of Science ®Google Scholar
• Zhang L, Tai YT, Ho MZG, Qiu L, Anderson KC. Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era. Exp Hematol Oncol. 2017;6(1):20. doi:10.1186/s40164-017-0081-628725493
   PubMed Web of Science ®Google Scholar
• Calabrò L, Di Giacomo AM, Altomonte M, et al. Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments? J Exp Clin Cancer Res. 2007;26:145–150.17550144
   PubMed Web of Science ®Google Scholar
• Radzikowska E, Szczepulska-Wójcik E, Chabowski M, Oniszh K, Langfort R, Roszkowski K. Pulmonary epithelioid haemangioendothelioma: interferon 2-alpha treatment—case report. Pneumonol Alergol Pol. 2008;76:281–285.18785134
   PubMedGoogle Scholar
• Liu XL, Yang ZY. Outcomes of hepatic epithelioid hemangioendothelioma with different managements: a retrospective investigation. Eur Rev Med Pharmacol Sci. 2021;25:4274–4282.34227062
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92(3):205–216. doi:10.1093/jnci/92.3.20510655437
   PubMed Web of Science ®Google Scholar
• Amin S, Chung H, Jha R. Hepatic epithelioid hemangioendothelioma: MR imaging findings. Abdom Imaging. 2011;36(4):407–414. doi:10.1007/s00261-010-9662-021079951
   PubMedGoogle Scholar
• Azzam RI, Alshak NS, Pham HP. AIRP best cases in radiologic-pathologic correlation: hepatic epithelioid hemangioendothelioma. Radiographics. 2012;32(3):789–794. doi:10.1148/rg.32311501022582359
   PubMed Web of Science ®Google Scholar
• Chen Y, Yu RS, Qiu LL, Jiang DY, Tan YB, Fu YB. Contrast-enhanced multiple phase imaging features in hepatic epithelioid hemangioendothelioma. World J Gastroenterol. 2011;17(30):3544–3553. doi:10.3748/wjg.v17.i30.354421941423
   PubMed Web of Science ®Google Scholar
• Lin J, Ji Y. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma. Hepatobiliary Pancreat Dis Int. 2010;9:154–158.20382586
   PubMed Web of Science ®Google Scholar
• Agrawal N, Parajuli S, Zhao P, et al. Liver transplantation in the management of hepatic epithelioid hemangioendothelioma: a single-center experience and review of the literature. Transplant Proc. 2011;43(7):2647–2650. doi:10.1016/j.transproceed.2011.06.03521911139
   PubMed Web of Science ®Google Scholar
• Fang C, Zhang W, Zheng S. Liver transplantation for hepatic epithelioid hemangioendothelioma: a case report and literature review. Int J Clin Exp Med. 2017;10:9693–9696.
   Web of Science ®Google Scholar
• Jung DH, Hwang S, Hong SM, et al. Clinicopathological features and prognosis of hepatic epithelioid hemangioendothelioma after liver resection and transplantation. Ann Transplant. 2016;21:784–790. doi:10.12659/AOT.90117228031549
   PubMed Web of Science ®Google Scholar
• Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991;110:726–734.1656538
   PubMed Web of Science ®Google Scholar
• Lerut JP, Orlando G, Sempoux C, et al. Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation. Transpl Int. 2004;17(4):202–207. doi:10.1111/j.1432-2277.2004.tb00429.x15114438
   PubMed Web of Science ®Google Scholar
• Grotz TE, Nagorney D, Donohue J, et al. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB. 2010;12(8):546–553. doi:10.1111/j.1477-2574.2010.00213.x20887322
   PubMed Web of Science ®Google Scholar
• Soape MP, Verma R, Payne JD, Wachtel M, Hardwicke F, Cobos E. Treatment of hepatic epithelioid hemangioendothelioma: finding uses for thalidomide in a new era of medicine. Case Rep Gastrointest Med. 2015;2015:326795.26167310
   PubMedGoogle Scholar
• Chevreau C, Le Cesne A, Ray-Coquard I, et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a Phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer. 2013;119(14):2639–2644. doi:10.1002/cncr.2810923589078
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Shimamura T, Tokuhisa M, Goto A, Ichikawa Y. Sorafenib monotherapy in a patient with unresectable hepatic epithelioid hemangioendothelioma. Case Rep Oncol. 2016;9(1):134–137. doi:10.1159/00044398627293400
   PubMed Web of Science ®Google Scholar
• Sangro B, Iñarrairaegui M, Fernández-Ros N. Malignant epithelioid hemangioendothelioma of the liver successfully treated with sorafenib. Rare Tumors. 2012;4(2):e34. doi:10.4081/rt.2012.e3422826791
   PubMedGoogle Scholar
• Pinet C, Magnan A, Garbe L, Payan MJ, Vervloet D. Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy. Eur Respir J. 1999;14(1):237. doi:10.1034/j.1399-3003.1999.14a40.x10489858
   PubMed Web of Science ®Google Scholar
• Woo JH, Kim TJ, Lee KS, Kim TS, Kim BT. Epithelioid hemangioendothelioma in the thorax: clinicopathologic, CT, PET, and prognostic features. Medicine. 2016;95(30):e4348. doi:10.1097/MD.000000000000434827472721
   PubMed Web of Science ®Google Scholar
• Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, Phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013;24(1):257–263. doi:10.1093/annonc/mds23722910841
   PubMed Web of Science ®Google Scholar
• Matthews SJ, McCoy C. Thalidomide: a review of approved and investigational uses. Clin Ther. 2003;25(2):342–395. doi:10.1016/S0149-2918(03)80085-112749503
   PubMed Web of Science ®Google Scholar
• Kassam A, Mandel K. Metastatic hepatic epithelioid hemangioendothelioma in a teenage girl. J Pediatr Hematol Oncol. 2008;30(7):550–552. doi:10.1097/MPH.0b013e31816e22d118797205
   PubMed Web of Science ®Google Scholar
• Raphael C, Hudson E, Williams L, Lester JF, Savage PM. Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report. J Med Case Rep. 2010;4(1):413. doi:10.1186/1752-1947-4-41321176188
   PubMedGoogle Scholar
• Salech F, Valderrama S, Nervi B, et al. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol. 2011;10(1):99–102. doi:10.1016/S1665-2681(19)31596-021301019
   PubMed Web of Science ®Google Scholar
• Stacchiotti S, Simeone N, Lo Vullo S, et al. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: a case-series analysis within the Italian Rare Cancer Network. Cancer. 2021;127(4):569–576. doi:10.1002/cncr.3324733107985
   PubMed Web of Science ®Google Scholar
• Engel ER, Cournoyer E, Adams DM, Stapleton S. A retrospective review of the use of sirolimus for pediatric patients with epithelioid hemangioendothelioma (EHE). J Pediatr Hematol Oncol. 2020;42(8):e826–e829. doi:10.1097/MPH.000000000000164331714437
   PubMed Web of Science ®Google Scholar
• Kayler LK, Merion RM, Arenas JD, et al. Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B. Transplantation. 2002;74(1):128–130. doi:10.1097/00007890-200207150-0002212134111
   PubMed Web of Science ®Google Scholar
• Asmana NR. Human interferon alpha-2b: a therapeutic protein for cancer treatment. Scientifica. 2014;2014:970315.24741445
   PubMedGoogle Scholar